Evidence map›Paper›PMID 22987116›Full record

ArticleInternational journal of cancer2013

Single cell molecular recognition of migrating and invading tumor cells using a targeted fluorescent probe to receptor PTPmu.

Susan M Burden-Gulley, Mohammed Q Qutaish, Kristin E Sullivant, Mingqian Tan, Sonya E L Craig, James P Basilion, Zheng-Rong Lu, David L Wilson, Susann M Brady-Kalnay

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07438860 (Fluorescence-Guided Imaging of Brain Tumors), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07438860 phase1not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2- ICG in a Phase 1 Clinical Trial

TypeinterventionalSponsorTiffany HodgesRan2026 to 2026Enrolled12ConditionsMalignant Brain Tumors, GliomaArmsSBK2-ICG, Craniotomy (Standard of Care)
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. PTPmu-targeted nanoparticles label invasive pediatric and adult glioblastoma.Nanomedicine : nanotechnology, biology, and medicine · 2020
    Article
  7. A PTPmu Biomarker is Associated with Increased Survival in Gliomas.International journal of molecular sciences · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Susan M Burden-GulleyDepartment of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, OH, USA. susann.brady-kalnay@case.edu
Mohammed Q Qutaish
Kristin E Sullivant
Mingqian Tan
Sonya E L Craig
James P Basilion
Zheng-Rong Lu
David L Wilson
Susann M Brady-Kalnay
Case Western Reserve University · US

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARK R CHANCE · 1987 to 2026
$142.3M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Interdisciplinary Biomedical Imaging Training ProgramT32EB007509 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI DAVID Lynn WILSON, Xin Yu · 2007 to 2026
$5.6M
Detecting invading glioma cells through in vivo molecular imaging of the cell surR01NS063971 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI BRADY-KALNAY, SUSANN M · 2009 to 2013
$1.9M
Whole Mouse Cryo-ImagingR42CA124270 · NCI · BIOINVISION, INC. · PI WILSON, DAVID LYNN · 2008 to 2009
$1.5M
NCATS NIH HHS UL1 TR000439NCI NIH HHS P30 CA043703NCI NIH HHS P30 CA43703NCI NIH HHS R42 CA124270NCI NIH HHS R42-CA124270NIBIB NIH HHS T32 EB007509NINDS NIH HHS R01 NS063971NINDS NIH HHS R01-NS063971
6 · The paper itself

Abstract

Detection of an extracellular cleaved fragment of a cell-cell adhesion molecule represents a new paradigm in molecular recognition and imaging of tumors. We previously demonstrated that probes that recognize the cleaved extracellular domain of receptor protein tyrosine phosphatase mu (PTPmu) label human glioblastoma brain tumor sections and the main tumor mass of intracranial xenograft gliomas. In this article, we examine whether one of these probes, SBK2, can label dispersed glioma cells that are no longer connected to the main tumor mass. Live mice with highly dispersive glioma tumors were injected intravenously with the fluorescent PTPmu probe to test the ability of the probe to label the dispersive glioma cells in vivo. Analysis was performed using a unique three-dimensional (3D) cryo-imaging technique to reveal highly migratory and invasive glioma cell dispersal within the brain and the extent of colabeling by the PTPmu probe. The PTPmu probe labeled the main tumor site and dispersed cells up to 3.5 mm away. The cryo-images of tumors labeled with the PTPmu probe provide a novel, high-resolution view of molecular tumor recognition, with excellent 3D detail regarding the pathways of tumor cell migration. Our data demonstrate that the PTPmu probe recognizes distant tumor cells even in parts of the brain where the blood-brain barrier is likely intact. The PTPmu probe has potential translational significance for recognizing tumor cells to facilitate molecular imaging, a more complete tumor resection and to serve as a molecular targeting agent to deliver chemotherapeutics to the main tumor mass and distant dispersive tumor cells.

Indexed as

Cell MovementMolecular Diagnostic TechniquesMolecular ProbesAnimalsBlood-Brain BarrierBrain NeoplasmsExtracellular SpaceFlow CytometryFluorescent DyesGlioblastomaMiceMice, NudePeptide FragmentsReceptor-Like Protein Tyrosine Phosphatases, Class 2Xenograft Model Antitumor AssaysFluorescent DyesMolecular ProbesPeptide FragmentsPTPRM protein, humanReceptor-Like Protein Tyrosine Phosphatases, Class 2

Identifiers

PMID22987116
PMCPMC3558593
OpenAlexW2037492592

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.